grant

Supplement to TR01 Human cortical development and neural plasticity altered by trisomy 21

Organization UNIVERSITY OF WISCONSIN-MADISONLocation MADISON, UNITED STATESPosted 10 Sept 2021Deadline 31 Aug 2026
NIHUS FederalResearch GrantFY202521+ years oldAccelerationAdultAdult HumanAffectAnimal ModelAnimal Models and Related StudiesAreaAssayAtlasesAwardBasic ResearchBasic ScienceBioassayBiologicalBiological AssayBody TissuesBrainBrain Nervous SystemCNS plasticityCell BodyCell modelCellsCellular modelCerebral cortexCognitive DisturbanceCognitive ImpairmentCognitive declineCognitive deficitsCognitive function abnormalComplementComplement ProteinsComplexDataData Coordinating CenterData Coordination CenterData SetDefectDevelopmentDevelopmental ProcessDiseaseDisorderDisturbance in cognitionDown SyndromeEncephalonFunctional RNAFundingFutureGenesGeneticGoalsHumanImpaired cognitionIn VitroIndividuals with down syndromeIntellectual disabilityIntellectual functioning disabilityIntellectual limitationInterventionLangdon Down syndromeModelingModern ManMolecularMolecular FingerprintingMolecular ProfilingMongolismNIH RFANational Institutes of HealthNerve CellsNerve UnitNeural CellNeurocyteNeurodevelopmental DisorderNeurological Development DisorderNeuronal DysfunctionNeuronal PlasticityNeuronsNon-Polyadenylated RNANoncoding RNANontranslated RNAOrganoidsPathway interactionsPlayPublic HealthRNARNA Gene ProductsRNA SeqRNA sequencingRNAseqRequest for ApplicationsResearchResearch ResourcesResourcesRibonucleic AcidRoleSynapsesSynapticSystemTherapeutic InterventionTissuesTranscriptTrisomy 21United States National Institutes of HealthUntranslated RNAadulthoodbasebasesbiologiccentral nervous system plasticitychromosome 21 trisomychromosome 21 trisomy syndromecognitive defectscognitive dysfunctioncognitive losscomplementationcongenital acromicria syndromedesigndesigningdevelopmentaldevelopmental diseasedevelopmental disorderdevelopmental geneticsdown syndrome individualsdown syndrome patientsglobal gene expressionglobal transcription profilehiPSChigh rewardhigh riskhuman iPShuman iPSChuman induced pluripotent cellhuman induced pluripotent stem cellshuman inducible pluripotent stem cellshuman inducible stem cellsiPSiPSCiPSCsinduced human pluripotent stem cellsinduced pluripotent cellinduced pluripotent stem cellinducible pluripotent cellinducible pluripotent stem cellinsightintellectual and developmental disabilityintervention therapylimited intellectual functioningmodel of animalmolecular profilemolecular signaturemorbus Downmultiomicsmultiple omicsneural dysfunctionneural plasticityneurodevelopmental diseaseneurogenesisneuron developmentneuronalneuronal developmentneuroplasticneuroplasticitynoncodingpanomicsparent awardparent projectpathwaypatients with down syndromepeople with down syndromepost-natal developmentpostnatal developmentprenatalprogenitor cell modelprogenitor modelpseudohypertrophic progressive muscular dystrophysocial rolestem and progenitor cell modelstem cell based modelstem cell derived modelstem cell modelsynapsesynapse formationsynaptogenesistranscriptometranscriptome sequencingtranscriptomic sequencingtranscriptomicstrisomy 21 syndromeunborn
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

ABSTRACT
Down syndrome (DS, trisomy 21, T21), a complex multigene disorder and the most common genetic cause of

intellectual disability. However, surprisingly little is known about the underlying mechanisms that lead to cognitive

impairment in DS. Reduced neurogenesis and synaptogenesis have been implicated as features of DS

development. Yet, what and how specific neurons and synaptic contacts are affected at which period of

development and what molecular pathways underlie these defects that lead to intellectual disability remain

unclear.

This supplement application requests funding to expand the goals of the parent award to carry out bulk whole

transcriptomics to identify diverse types of RNA species that cannot be captured using the single cell approaches

in the parent award. These results will complement the single cell results generated from the parent award and

potentially identify new gene regulatory mechanisms in DS brain development. The supplement proposal is

relevant to Component 1 of the NIH INCLUDE project: Targeted high risk - high reward basic science studies in

areas highly relevant to Down syndrome. Data generated from this award will be shared as a resource through

the INCLUDE Data Coordinating Center (DCC) to maximize and accelerated research in Down syndrome.

Grant Number: 3R01HD106197-03S1
NIH Institute/Center: NIH

Principal Investigator: ANITA BHATTACHARYYA

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →